Diagnostics News and Research

RSS

Beckman Coulter Life Sciences established as first us distributor of genedrive plc COVID-19 kit

As the world continues to seek solutions in response to the coronavirus pandemic, Beckman Coulter Life Sciences announces it is the first United States distributor of the Genedrive® 96 SARS-CoV-2 kit. The agreement with the near-patient molecular diagnostics company, genedrive plc (LSE: GDR), is for distribution in the US and throughout Europe.

From Beckman Coulter Life Sciences - Flow Cytometry 23 Feb 2021

POU1F1 gene variant linked to pituitary dwarfism in Karelian Bear Dogs

A study carried out at the University of Helsinki investigated pituitary dwarfism in Karelian Bear Dogs and found a link to a variant of the POU1F1 gene. The results can also help understand the gene's significance to the human pituitary gland's development and function.

22 Feb 2021

FDA issues guidance for medical product developers to address the emergence of SARS-CoV-2 variants

Today, the U.S. Food and Drug Administration issued guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes COVID-19.

22 Feb 2021

Antimicrobial resistance to critical drugs spirals in low- and middle-income countries

As antibiotic use grows in lower-income countries so does antibiotic resistance, says report.

20 Feb 2021

Researchers use zebrafish to study cancer-immune interactions

Cancer researcher Rita Fior uses zebrafish to study human cancer. Though this may seem like an unlikely match, her work shows great promise with forthcoming applications in personalized medicine.

19 Feb 2021

Zambia study casts doubt on the assumption that COVID-19 skipped Africa

A new study concluding out of Lusaka, Zambia last summer has found that as many as 19% (almost 1 in 5) of recently-deceased people tested positive for COVID-19.

18 Feb 2021

How has 3D printing come to the aid of healthcare during the COVID-19 pandemic?

In the study, published in the journal Emergent Materials, the researchers identified the role of 3D printing in COVID-19. During the pandemic, over 100 various 3D printable PPE designs have been used.

18 Feb 2021

Analyzing short strands of cell-free DNA in urine could help detect early-stage cancer

Urinalysis has long been a staple of physical exams to detect and manage a number of diseases and disorders, but not cancer.

18 Feb 2021

New study to explore how Apple Watch can provide early warning for worsening heart failure

As part of the University Health Network, renowned cardiologist Dr. Heather Ross has launched a new clinical study, in collaboration with Apple to test if remote monitoring with Apple Watch can help with early identification of worsening heart failure.

18 Feb 2021

New diagnostic platform can rapidly measure COVID-19-related biomarkers

The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute's eRapid technology with the company's proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.

18 Feb 2021

Scientists to develop highly sensitive antibody tests for infection caused by all coronaviruses

Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.

17 Feb 2021

Study suggests a new way to personalize anti-CTLA-4 therapy for cancers

A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors.

15 Feb 2021

LifeArc supports the GenOMICC COVID-19 Study

Medical research charity, LifeArc, announces today that it is providing £5 million funding to support the work of the GenOMICC COVID-19 Study, led by the GenOMICC consortium in partnership with Genomics England.

15 Feb 2021

Study finds certain plasma microRNAs as diagnostic biomarkers for mild traumatic brain injury

Certain plasma microRNAs could serve as diagnostic biomarkers in mild traumatic brain injury, a new study from the University of Eastern Finland shows.

15 Feb 2021

Algorithm for skin cancer diagnosis performs on par with dermatologists

A study has now been presented that boosts the evidence for using AI solutions in skin cancer diagnostics.

13 Feb 2021

Using a smartphone-based microscope for detecting single molecules and diagnosing diseases

Biomarkers play a central role in the diagnosis of disease and assessment of its course. Among the markers now in use are genes, proteins, hormones, lipids and other classes of molecules.

13 Feb 2021

New zebrafish model could help advance glioblastoma multiforme research

Scientists at the Fralin Biomedical Research Institute at VTC have identified a new zebrafish model that could help advance glioblastoma multiforme research. Glioblastoma is an aggressive form of primary brain tumor - fewer than one in 20 patients survive five years after diagnosis.

13 Feb 2021

Mobile phone app may help diagnose Parkinson's disease

Voice samples, motion patterns, and finger movements as the screen is touched — all easily monitored with the possibility to help diagnose Parkinson's disease.

13 Feb 2021

The Future of Environmental and Food Monitoring

NewsMed interviews Professor Antje Baeumner about the future of food and environmental monitoring, the subject of her 2021 Pittcon presentation.

From Pittcon 12 Feb 2021

Novel tool guides evaluation of patients who develop COVID-19 symptoms

When patients arrive in emergency departments and hospitals with symptoms consistent with COVID-19, it's critical to isolate them to avoid the potential spread of infection, but keeping patients isolated longer than needed could delay patient care, take up hospital beds needed for other patients, and unnecessarily use up personal protective equipment.

10 Feb 2021

Diagnostics News and Research

Beckman Coulter Life Sciences established as first us distributor of genedrive plc COVID-19 kit

POU1F1 gene variant linked to pituitary dwarfism in Karelian Bear Dogs

FDA issues guidance for medical product developers to address the emergence of SARS-CoV-2 variants

Antimicrobial resistance to critical drugs spirals in low- and middle-income countries

Researchers use zebrafish to study cancer-immune interactions

Zambia study casts doubt on the assumption that COVID-19 skipped Africa

How has 3D printing come to the aid of healthcare during the COVID-19 pandemic?

Analyzing short strands of cell-free DNA in urine could help detect early-stage cancer

New study to explore how Apple Watch can provide early warning for worsening heart failure

New diagnostic platform can rapidly measure COVID-19-related biomarkers

Scientists to develop highly sensitive antibody tests for infection caused by all coronaviruses

Study suggests a new way to personalize anti-CTLA-4 therapy for cancers

LifeArc supports the GenOMICC COVID-19 Study

Study finds certain plasma microRNAs as diagnostic biomarkers for mild traumatic brain injury

Algorithm for skin cancer diagnosis performs on par with dermatologists

Using a smartphone-based microscope for detecting single molecules and diagnosing diseases

New zebrafish model could help advance glioblastoma multiforme research

Mobile phone app may help diagnose Parkinson's disease

The Future of Environmental and Food Monitoring

Novel tool guides evaluation of patients who develop COVID-19 symptoms

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News